CVRx, Inc. financial data

Symbol
CVRX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.14K % -18.1%
Quick Ratio 118 % -7.58%
Debt-to-equity 79.7 % +150%
Return On Equity -93.1 % -96.7%
Return On Assets -51.8 % -44.3%
Operating Margin -116 % -5.73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26M shares +24.4%
Common Stock, Shares, Outstanding 25.3M shares +21.3%
Entity Public Float 153M USD -19.7%
Common Stock, Value, Issued 253K USD +21.1%
Weighted Average Number of Shares Outstanding, Basic 22.6M shares +8.88%
Weighted Average Number of Shares Outstanding, Diluted 22.6M shares +8.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 51.3M USD +30.5%
Cost of Revenue 8.33M USD +33.2%
Research and Development Expense 11.1M USD -4.32%
Operating Income (Loss) -59.5M USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -59.9M USD -45.9%
Income Tax Expense (Benefit) 55K USD -62.6%
Net Income (Loss) Attributable to Parent -60M USD -45.6%
Earnings Per Share, Basic -2.65 USD/shares -33.2%
Earnings Per Share, Diluted -2.65 USD/shares -33.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106M USD +17%
Accounts Receivable, after Allowance for Credit Loss, Current 9.27M USD +22.7%
Inventory, Net 12.1M USD +10.2%
Assets, Current 130M USD +15.8%
Property, Plant and Equipment, Net 2.51M USD +42.1%
Operating Lease, Right-of-Use Asset 1.07M USD -20.8%
Other Assets, Noncurrent 27K USD 0%
Assets 133M USD +15.8%
Accounts Payable, Current 2.58M USD +37%
Employee-related Liabilities, Current 274K USD -2.14%
Accrued Liabilities, Current 8.18M USD +36.8%
Liabilities, Current 10.8M USD +36.9%
Operating Lease, Liability, Noncurrent 877K USD -24.4%
Other Liabilities, Noncurrent 1.45M USD +39.7%
Liabilities 62.4M USD +58.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -206K USD +0.48%
Retained Earnings (Accumulated Deficit) -537M USD -12.6%
Stockholders' Equity Attributable to Parent 71.1M USD -6.44%
Liabilities and Equity 133M USD +15.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -6.31%
Net Cash Provided by (Used in) Financing Activities 1.36M USD -82%
Net Cash Provided by (Used in) Investing Activities -917K USD -282%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 25.3M shares +21.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.5M USD -258%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD +17%
Interest Paid, Excluding Capitalized Interest, Operating Activities 770K USD +310%
Deferred Tax Assets, Valuation Allowance 122M USD +10.4%
Deferred Tax Assets, Gross 122M USD +10.4%
Operating Lease, Liability 1.16M USD -16.7%
Depreciation 619K USD +18.6%
Payments to Acquire Property, Plant, and Equipment 917K USD +282%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60M USD -45.5%
Lessee, Operating Lease, Liability, to be Paid 1.31M USD -19.4%
Property, Plant and Equipment, Gross 5.91M USD +29.9%
Operating Lease, Liability, Current 282K USD +22.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 362K USD +3.43%
Lessee, Operating Lease, Liability, to be Paid, Year One 350K USD +11.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 150K USD -35.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 374K USD +3.32%
Deferred Tax Assets, Operating Loss Carryforwards 98.3M USD +10.3%
Unrecognized Tax Benefits 2.35M USD +5.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 223K USD -40.4%
Operating Lease, Payments 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 19.1M USD +202%
Interest Expense 2.52M USD +522%